作者:
Jarow,J.P. [1]
;
Lerner,S.P. [2]
;
Kluetz,P.G. [3]
;
Liu,K. [4]
;
Sridhara,R. [5]
;
Bajorin,D. [6]
;
Chang,S. [7]
;
Dinney,C.P.N. [8]
;
Groshen,S. [9]
;
Morton,R.A. [10]
;
O'Donnell,M. [11]
;
Quale,D.Z. [12]
;
Schoenberg,M. [13]
;
Seigne,J. [14]
;
Vikram,B.
作者单位:
Division of Biometrics v, Office of Biostatistics, CDER, Food and Drug Administration, Silver
[1]
Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food
[2]
University of Texas, MD Anderson Cancer Center, Houston, TX, United States
[3]
Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, NH, United States
[4]
Johns Hopkins University School of Medicine, Baltimore, MD, United States
[5]
Food and Drug Administration, Office of Hematology and Oncology Products, Silver Spring, MD 20993
[6]
Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, United States
[7]
American Medical Systems, Minnetonka, MN, United States
[8]
Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, USC/Keck School of
[9]
Bladder Cancer Advocacy Network, Bethesda, MD, United States
[10]
University of Iowa, Iowa city, IA, United States
[11]
National Cancer Institute, Bethesda, MD, United States
[12]
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, United States
[13]
Scott Department of Urology, Baylor College of Medicine Medical Center, Houston, TX, United States
[14]
发布时间
2014-07-29